Ajanta Pharma announces e-voting schedule for 47th AGM

1 min read     Updated on 19 Jun 2026, 12:16 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Ajanta Pharma has announced the schedule for remote e-voting and its Forty-Seventh Annual General Meeting (AGM). The AGM will be held virtually on July 16, 2026. Remote e-voting is open from July 13 to July 15 for shareholders eligible as of July 9, 2026.

powered bylight_fuzz_icon
43040913

*this image is generated using AI for illustrative purposes only.

Ajanta Pharma has published the notice for e-voting and its Forty-Seventh Annual General Meeting (AGM) in the Mumbai editions of Free Press Journal and Navshakti on June 19, 2026. The meeting is scheduled to be held on July 16, 2026, at 11:00 a.m. IST via video conferencing. This disclosure complies with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 108 of the Companies Act, 2013.

The company has dispensed with the requirement of sending physical copies of the Notice and Annual Report for FY 2025-26. Instead, these documents were emailed to members on June 18, 2026, and are available on the company's website. The facility for remote e-voting will be available to members holding shares in physical or dematerialised form as on the cut-off date of July 9, 2026.

E-Voting and AGM Schedule

Event Date Time
Remote E-Voting Commences July 13, 2026 9:00 a.m. IST
Remote E-Voting Ends July 15, 2026 5:00 p.m. IST
Annual General Meeting July 16, 2026 11:00 a.m. IST
Cut-off Date (Voting Eligibility) July 9, 2026 -

Shareholders who cast their vote via remote e-voting prior to the AGM may attend the meeting but are not entitled to vote again. Those who have not voted remotely can exercise their right through the e-voting system during the AGM. The venue of the meeting is deemed to be the Registered Office of the company in Mumbai.

Historical Stock Returns for Ajanta Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.04%+5.31%+13.04%+28.79%+27.99%+138.34%

What key resolutions are expected to be presented during the AGM that could influence Ajanta Pharma's strategic direction?

How might the shift to fully digital distribution of annual reports impact shareholder engagement and participation levels?

What are the anticipated market reactions to the outcomes of the e-voting, particularly regarding potential dividend declarations or board changes?

Ajanta Pharma promoter pledges shares for new loan

2 min read     Updated on 15 Jun 2026, 11:21 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Aayush Agrawal, a promoter of Ajanta Pharma, pledged 11,11,111 shares to RBL Bank Ltd for a new loan. The total encumbered shares for the Aayush Agrawal Trust increased to 1,25,56,198, or 10.05% of the company's share capital. The disclosure was made to comply with SEBI (SAST) Regulations, 2011.

powered bylight_fuzz_icon
42526922

*this image is generated using AI for illustrative purposes only.

Aayush Agrawal, a promoter of Ajanta Pharma , has created a pledge on 11,11,111 shares to secure a new loan, according to a regulatory filing submitted on June 12, 2026. The shares were pledged in favor of RBL Bank Ltd. The disclosure was made in compliance with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The filing details the shareholding and encumbrance status of various promoter entities. Aayush Agrawal, as trustee of the Aayush Agrawal Trust, holds a total of 1,41,12,924 shares, accounting for 11.30% of the company. Following the pledge creation on June 10, 2026, the total encumbered holding for this entity stands at 1,25,56,198 shares, representing 10.05% of the total share capital.

The transaction involved two separate pledge creations on the same date. The first pledge covered 8,92,860 shares, and the second covered 2,18,251 shares. Both were created for the purpose of a new loan.

Other promoter entities listed in the disclosure include Gabs Investments Pvt Ltd, which holds 27,70,000 encumbered shares, and trusts associated with key individuals such as Yogesh M Agrawal, Rajesh M Agrawal, and Ravi P Agrawal. While some entities hold existing encumbered shares, the recent pledge activity is specific to Aayush Agrawal as trustee of the Aayush Agrawal Trust.

The following table summarizes the shareholding and encumbrance details disclosed by the promoters:

Name of the promoter(s) or PACs Promoter holding (Number) Promoter holding (%) Promoter holding already encumbered (Number) Promoter holding already encumbered (%) Post event holding of encumbered shares (Number) Post event holding of encumbered shares (%)
Gabs Investments Pvt Ltd 1,25,88,393 10.08 27,70,000 2.22 27,70,000 2.22
Yogesh M Agrawal, trustee Yogesh Agrawal Trust 1,80,78,147 14.47 - - - -
Mannalal B Agrawal 0 0.00 - - - -
Rajesh M Agrawal, trustee Rajesh Agrawal Trust 1,80,78,148 14.47 - - - -
Ravi P Agrawal, trustee Ravi Agrawal Trust 1,27,92,904 10.24 57,56,777 4.61 57,56,777 4.61
Ravi P. Agrawal 2,85,000 0.23 - - - -
Aayush M Agrawal, trustee Aayush Agrawal Trust 1,41,12,924 11.30 1,23,37,947 9.88 1,25,56,198 10.05
Aayush M. Agrawal 30,000 0.02 - - - -
Ganga Exports represented by its partners Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal 33,48,261 2.68 - - - -

The document was signed by Aayush Agrawal, Trustee of the Aayush Agrawal Trust, and addressed to BSE Limited and the National Stock Exchange of India.

Historical Stock Returns for Ajanta Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.04%+5.31%+13.04%+28.79%+27.99%+138.34%

What is the specific purpose of the new loan secured by Aayush Agrawal, and will it be utilized for personal needs or corporate expansion?

How will the increased pledge level, now covering nearly 89% of Aayush Agrawal's trust holdings, impact investor confidence in Ajanta Pharma's governance?

Does this high level of encumbrance increase the risk of a margin call triggering a sell-off in the event of a market downturn?

More News on Ajanta Pharma

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+27.99%